AcelRx Pharmaceuticals Inc. | Mutual Funds
Mutual Funds that own AcelRx Pharmaceuticals Inc.
Vanguard Total Stock Market Index Fund
1,246,810
2.06%
202,100
0%
07/31/2018
Vanguard Extended Market Index Fund
663,268
1.1%
171,659
0%
07/31/2018
Bridgeway Ultra Small Company Market Fund
241,150
0.4%
-40,000
0.17%
12/31/2017
Fidelity Select Biotechnology Portfolio
226,844
0.37%
0
0.01%
07/31/2018
Fidelity Spartan Extended Market Index Fund
160,628
0.27%
0
0%
07/31/2018
iShares Micro Cap ETF
112,039
0.19%
0
0.03%
09/06/2018
Vanguard Institutional Total Stock Market Index Fund
77,047
0.13%
16,100
0%
07/31/2018
Fidelity Advisor Biotechnology Fund
71,800
0.12%
0
0.01%
07/31/2018
Fidelity Spartan Total Market Index Fund
65,025
0.11%
0
0%
07/31/2018
Vanguard Balanced Index Fund
43,056
0.07%
0
0%
07/31/2018
| Address |
351 Galveston Drive
Redwood City California 94063
United States
|
|
Employees
|
- |
| Website |
http://www.acelrx.com |
| Updated |
07/08/2019 |
| AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of acute pain. Its products include DSUVIA and ZALVISO. The company was founded by Thomas A. |
